Harbor Capital Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-96,837
| Closed | -$433K | – | 727 |
|
|
2024
Q1 | $433K | Buy |
96,837
+23,327
| +32% | +$104K | 0.06% | 433 |
|
|
2023
Q4 | $236K | Buy |
73,510
+4,991
| +7% | +$16K | 0.05% | 341 |
|
|
2023
Q3 | $217K | Buy |
68,519
+10,473
| +18% | +$33.2K | 0.05% | 347 |
|
|
2023
Q2 | $288K | Buy |
58,046
+5,288
| +10% | +$26.3K | 0.06% | 324 |
|
|
2023
Q1 | $261K | Buy |
52,758
+10,957
| +26% | +$54.1K | 0.08% | 193 |
|
|
2022
Q4 | $263K | Sell |
41,801
-19,493
| -32% | -$123K | 0.26% | 75 |
|
|
2022
Q3 | $662K | Sell |
61,294
-28,698
| -32% | -$310K | 0.61% | 54 |
|
|
2022
Q2 | $1.03M | Sell |
89,992
-2,763
| -3% | -$31.5K | 0.78% | 37 |
|
|
2022
Q1 | $845K | Sell |
92,755
-26,792
| -22% | -$244K | 0.4% | 68 |
|
|
2021
Q4 | $1.78M | Buy |
+119,547
| New | +$1.78M | 0.65% | 49 |
|